Company profile
HERON THERAPEUTICS, INC. /DE/ insider acquisitions
Company CIK 0000818033 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Exercise / conversionCode M | Common StockNon-derivative · Currency not specified | 3 | Not applicable | 3 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
12 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 19, 2026 | HERON THERAPEUTICS, INC. /DE/Common Stock | Duarte Ira | Exercise / conversion |
| Oct 19, 2026 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
| Oct 19, 2026 | HERON THERAPEUTICS, INC. /DE/Common Stock | Collard Craig A | Exercise / conversion |
| Nov 8, 2025 | HERON THERAPEUTICS, INC. /DE/Stock Option (Right to Buy) | Cusack Thomas | Stock award |
| Nov 8, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Cusack Thomas | Stock award |
| Oct 31, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
| Oct 31, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Duarte Ira | Exercise / conversion |
| Oct 31, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Collard Craig A | Exercise / conversion |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Duarte Ira | Exercise / conversion |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Collard Craig A | Exercise / conversion |
| Oct 15, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock, par value $0.01 per share ("Common Stock") | Rubric Capital Management LP · Rosen David Efraim | Conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
HRTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Duarte IraEVP, Chief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Collard Craig AChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 13,797 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Cusack ThomasDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 227,272 | 1.1Value: 249,999.2Currency not specified | View ↗ |
| Trade: | Cusack ThomasDirector | Stock awardCommon StockNon-derivative security · Code A | 37,879 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 11,694 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Duarte IraEVP, Chief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 11,694 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Collard Craig AChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 34,789 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Duarte IraEVP, Chief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Collard Craig AChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 13,797 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Rubric Capital Management LP10% owner Rosen David Efraim10% owner Joint filing · amounts unallocated | ConversionCommon Stock, par value $0.01 per share ("Common Stock")Non-derivative security · Code C | 946,100 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
12 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →